About the Journal

Global Biomedical Frontiers is an open-access journal published by VitaFront Press. It provides a platform for original research across the biomedical sciences, with particular emphasis on molecular and cellular biology, immunology, natural-product pharmacology, and translational medicine. The journal welcomes studies that advance understanding of disease mechanisms, immune regulation, bioactive compounds, and therapeutic innovation.

All submissions undergo peer review. Accepted articles are published open access to support broad dissemination of biomedical research.

Aims & Scope

The journal covers, but is not limited to, the following areas:

• Molecular biology, biotechnology, and gene engineering
• Immunology, cytokines, and immune modulation
• Natural products and polysaccharide-based therapeutics
• Oncology, tumor microenvironment, and anti-tumor mechanisms
• Pharmacology, metabolic regulation, and preclinical biomedical studies
• Translational and interdisciplinary biomedical research

Publisher & Contact

Publisher: VitaFront Press
Website: https://www.vifpress.com
US Headquarters: 14471 Chambers Unit 206, Tustin, CA 92780, USA
Tel.: +(1) 840-256-9141 / +(1) 949-343-2754
Fax: +1 248-245-7108
Email: tjs@vifpress.com / TjolieDenver@hotmail.com

Editorial Board

Chief Editor: Ph.D. Ning Tao
Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, China
Email: tao@ibp.ac.cn

Associate Chief Editor: Associate Prof. Caixia Dong
Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, China
Email: dongcaixia@tmu.edu.cn

Associate Chief Editor: Ph.D. Jing Ma
Department of Pathology, The Affiliated Hospital, Southwest Medical University, China
Email: majing0604@gmail.com

Editor: Mr. Boyuan Hu
Department of Biomedical Engineering, LKS Faculty of Medicine, The University of Hong Kong, HKSAR
Email: u3666821@connect.hku.hk